Name: Latest research reports of Abbott India Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Falling Comet

25550.0000 -235.00 (-0.91%)

NSE Apr 20, 2026 15:31 PM

New 52W Low in past week

Volume: 14,619

Abbott India Ltd.

27 Nov 2025

25550.00

-0.91%

Abbott India (BUY): Visibility of margin improvement

Buy: Abbott India Ltd.

BOB Capital Markets Ltd.

Mixtard 50 injectables off the shelf from Aug'25, yet monthly sales were Rs705 mn inAug'25, 762 mn in Sep'25 and Rs 710 mn in Oct'25

Abbott India Ltd. has an average target of 35280.00 from 4 brokers.